Browse by all authors Browse By Author Name - Ross,+F.+B.

Browse Results (20 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Nielsen, C., Ross, F. B. and Smith, M. T. (2000). Absence of antinociceptive cross-tolerance between supraspinal oxycodone and intravenous morphine in the dark agouti rat. In: W. C. Hodgson and R. E. Loiacono, Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting, Newcastle, Australia, (40-40). 3-6 December, 2000. 95  
Nielsen, C., Ross, F. B., Lewis, R. J., Drinkwater, R. D. and Smith, M. T. (2002). Anti-allodynic efficacy of the conopeptide, MR1A, in rats with neuropathic pain. In: Abstracts 10th World Congress on Pain. 10th World Congress on Pain, San Diego, (278-278). 17-22 Aug. 2002. 64  
Nielsen, C., Ross, F. B., Lewis, R. J., Drinkwater, R. D. and Smith, M. T. (2002). Anti-allodynic efficacy of the x-conipeptide, MR1A, in rats with neuropathic pain. In: Proceedings of the Australian Health and Medical Research Congress. AHMR Congress 2002, Melbourne, (2035-2035). 24-29 Nov. 2002. 54  
Smith, M. T., Ross, F. B., Lewis, R., Kurek, J. and Cabot, P. J. (2000). Antinociceptive efficacy of intrathecal AM336 for the relief of adjuvant-induced chronic inflammatory pain in the rat hindpaw. In: R. E. Widdop and C. G. Sobey, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Joint Meeting of ASCEPT and the British Pharmacological Society, Melbourne, Australia, (50-50). 26 - 28 April, 2000. 89  
Ross, F. B., Cabot, P. J., Robertson, A. D. and Smith, M. T. (1999). Antinociceptive potencies and motor effects of the calcium channel blockers, AM336 and ziconotide, following intrathecal administration to FCA-treated rats. In: Marshall Devor, Abstracts of the 9th World Congress on Pain. 9th World Congress on Pain, Vienna, Austria, (292-292). 22 - 27 August, 1999. 62  
Lotfipour, S., Ross, F. B., Brown, L. C. and Smith, M. T. (2005). Chronic administration of dietary L-Arginine reverses opioid hyposensitivity for the relief of tactile allodynia in a rat model of diabetic neuropathy. In: Abstracts, 11th World Congress on Pain. 11th World Congress on Pain, Sydney, (1783-P286). 21-26 August 2005. 76  
Patterson, M., Ross, F. B. and Smith, M. T. (2001). Differential changes in the potency of supraspinally administered oxycodone relative to morphine for the alleviation of tactile allodynia in adult male Dark Agouti rats with streptozotocin-induced diabetes. In: W.C. Hodgson and R.E. Loiacono, Abstracts of the Annual Scientific Meeting of ASCEPT. ASCEPT Annual Scientific Meeting, Dunedin, New Zealand, (80-80). 3 - 5 December, 2001. 51  
Ross, F. B., Saini, K. and Smith, M. T. (2000). Differential potency of subcutaneous morphine and oxycodone for the relief of mechanical allodynia in dark agouti rats with a chronic constriction injury (CCI) of the sciatic nerve. In: W. C. Hodgson and R. E. Loiacono, Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting, Newcastle, Australia, (84-84). 3 - 6 December, 2000. 52  
Nielsen, C., Ross, F. B. and Smith, M. T. (2000). Incomplete and assymetric antinociceptive cross-tolerance between oxycodone and morphine in the rat. In: R. E. Widdop and C. G. Sobey, Proceedings of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. Joint Meeting of ASCEPT and the British Pharmacological Society, Melbourne, Australia, (109-109). 26 - 28 April, 2000. 50  
Nielsen, C., Ross, F. B. and Smith, M. T. (1999). Incomplete antinociceptive cross-tolerance between oxycodone and morphine in the rat. In: Marshall Devor, Abstracts of the 9th World Congress on Pain. 9th World Congress on Pain, Vienna, Austria, (533-533). 22 - 27 August, 1999. 58  
Nielsen, C. K., Ross, F. B. and Smith, M. T. (2000) Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat. Journal of Pharmacology and Experimental Therapeutics, 295 1: 91-99. 156   37
Ross, F. B., Saini, K. and Smith, M. T. (2001). Increased potency of single doses of subcutaneous oxycodone, but not morphine, in Dark Agouti rats with a chronic constriction injury (CCI) of the sciatic nerve relative to control rats.. In: J. O'Callaghan, Proceedings of 22nd Annual Scientific Meeting of Australian Pain Society. 22nd Annual Scientific Meeting of Australian Pain Society, Cairns, Qld, (37-37). 8-12 April 2001. 116  
Cabot, P. J., Ross, F. B., Robertson, A. D. and Smith, M. T. (1999). Inhibition of K+-evoked substance P release from slices of rat spinal cord by the novel calcium channel blockers, AM336 and AM543, relative to ziconotide. In: Marshall Devor, Abstracts of the 9th World Congress on Pain. 9th World Congress on Pain, Vienna, Austria, (292-292). 22 - 27 August, 1999. 50  
Smith, M. T., Ross, F. B., Lewis, R., Kurek, J. and Cabot, P. J. (2000). Lack of cross-tolerance between intrathecal AM336 and intravenous morphine in contrast to the marked cross-tolerance between ziconotide and morphine. In: W. C. Hodgson and R. E. Loiacono, Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting, Newcastle, Australia, (84-84). 3 - 6 December, 2000. 73  
Lotfipour, S., Ross, F. B., Saini, K. and Smith, M. T. (2002). Oxycodone, but not morphine, is efficacious for the relief of tactile allodynia in diabetic rats at three and six months after the induction of diabetes with streptozotocin. In: Abstracts 10th World Congress on Pain. 10th World Congress on Pain, San Diego, (510-510). 17-22 Aug. 2002. 84  
Nielsen, C., Smith, M. T. and Ross, F. B. (2001). Preliminery investigation of the ability of oxycodone to stimulate agonist-induced internalisation of the m-opioid receptor. In: W.C. Hodgson and R.E. Loiacono, Abstracts of the Annual Scientific Meeting of ASCEPT. Annual Scientific Meeting of ASCEPT, Dunedin, New Zealand, (79-79). 3 - 5 December, 2001. 78  
Smith, M. T., Patterson, M. and Ross, F. B. (2002). Supraspinally administered oxycodone has intrinsic anti-allodynic effects for the alleviation of tactile allodynia in adult male rats with streptozotocin-induced diabetes. In: H. Flor, E. Kalso and J. O. Dostrovsky, Abstracts, 10th World Congress on Pain. 10th World Congress on Pain, San Diego, (507-508). 17-22 August 2002. 48  
Smith, M. T., Ross, F. B., Lotfipour, S. and Saini, K. (2001). Temporal changes in the potency of subcutaneous oxycodone relative to morphine for the alleviation of tactile allodynia in Dark Agouti Rats with diabetes secondary to streptozotocin injection. In: W.C. Hodgson and R.E. Loiacono, Abstracts of the Annual Scientific Meeting of ASCEPT. Annual Scientific Meeting of ASCEPT, Dunedin, New Zealand, (38-38). 3 - 5 December, 2001. 57  
Smith, M. T., Cabot, P. J., Ross, F. B., Robertson, A. D. and Lewis, R. J. (2002) The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices.. Pain, 96 1-2: 119-127. doi:10.1016/S0304-3959(01)00436-5 155   105 Cited 118 times in Scopus118 0
Wei, M., Ong, L., Smith, M. T., Ross, F. B., Schmid, K., Hoey, A., Burstow, D. J. and Brown, L. C. (2003) The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes. Heart, Lung and Circulation, 2003 12: 44-50. 172   Cited 56 times in Scopus56